Education
About Us
Working with TipRanks
Follow Us
Sionna Therapeutics, Inc. (SION)
:SION
Total Valuation
Sionna Therapeutics, Inc. has a market cap or net worth of $574.06M. The enterprise value is $544.98M.
Market Cap$574.06M
Enterprise Value$544.98M
Share Statistics
Sionna Therapeutics, Inc. has 44,124,393 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding44,124,393
Owned by Insiders53.96%
Owned by Institutions2.21%
Financial Efficiency
Sionna Therapeutics, Inc.’s return on equity (ROE) is 0.38 and return on invested capital (ROIC) is -40.00%.
Return on Equity (ROE)0.38
Return on Assets (ROA)-0.33
Return on Invested Capital (ROIC)-40.00%
Return on Capital Employed (ROCE)-0.40
Revenue Per Employee0.00
Profits Per Employee-1.50M
Employee Count41
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Sionna Therapeutics, Inc. is -17.20. Sionna Therapeutics, Inc.’s PEG ratio is 0.09.
PE Ratio-17.20
PS Ratio0.00
PB Ratio1.06
Price to Fair Value-6.48
Price to FCF-12.63
Price to Operating Cash Flow-7.65
PEG Ratio0.09
Income Statement
In the last 12 months, Sionna Therapeutics, Inc. had revenue of 0.00 and earned -61.69M in profits. Earnings per share was -1.45.
Revenue0.00
Gross Profit0.00
Operating Income-70.56M
Pretax Income-61.69M
Net Income-61.69M
EBITDA-69.89M
Earnings Per Share (EPS)-1.45
Cash Flow
In the last 12 months, operating cash flow was -28.07M and capital expenditures -86.00K, giving a free cash flow of -28.18M billion.
Operating Cash Flow-28.07M
Free Cash Flow-28.18M
Free Cash Flow per Share-0.64
Dividends & Yields
Sionna Therapeutics, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.29
52-Week Price Change-42.81%
50-Day Moving Average12.13
200-Day Moving Average―
Relative Strength Index (RSI)51.39
Average Volume (3m)142.89K
Important Dates
Sionna Therapeutics, Inc. upcoming earnings date is May 12, 2025, TBA Not Confirmed.
Last Earnings DateMar 20, 2025
Next Earnings DateMay 12, 2025
Ex-Dividend Date―
Financial Position
Sionna Therapeutics, Inc. as a current ratio of 14.49, with Debt / Equity ratio of 2.70%
Current Ratio14.49
Quick Ratio14.49
Debt to Market Cap0.00
Net Debt to EBITDA0.40
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Sionna Therapeutics, Inc. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Sionna Therapeutics, Inc. EV to EBITDA ratio is -14.78, with an EV/FCF ratio of -19.56.
EV to Sales0.00
EV to EBITDA-14.78
EV to Free Cash Flow-19.56
EV to Operating Cash Flow-19.57
Balance Sheet
Sionna Therapeutics, Inc. has $269.67M in cash and marketable securities with $9.50M in debt, giving a net cash position of -$260.17M billion.
Cash & Marketable Securities$269.67M
Total Debt$9.50M
Net Cash-$260.17M
Net Cash Per Share-$5.90
Tangible Book Value Per Share-$3.86
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Sionna Therapeutics, Inc. is $38.50, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$38.50
Price Target Upside198.45% Upside
Analyst ConsensusStrong Buy
Analyst Count3
Revenue Growth Forecast―
EPS Growth Forecast―